Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 90
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Am J Cardiol ; 82(3): 338-44, 1998 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-9708664

RESUMO

In chronic congestive heart failure (CHF) an overactivity of muscle ergoreceptors and peripheral chemoreceptors may lead to an increased ventilatory response to exercise and contribute to the autonomic imbalance. The analysis of heart rate variability (HRV), which is a reliable method of studying autonomic regulations within the cardiovascular system, showed depressed HRV indexes in CHF, but predictors of abnormal HRV pattern in CHF remain controversial. Considering a common mechanism involved in generation of both abnormal ventilation and autonomic dysfunction in CHF, we hypothesized that impaired ventilation may be better than other variables of CHF severity in determining HRV parameters. Seventy-two patients with CHF (57+/-9 years, ejection fraction: 28+/-11%) underwent cardiopulmonary exercise testing; the relation between ventilation and carbon dioxide production (VE/VCO2) was used as an index of the ventilatory response to exercise. Time and frequency-domain measurements of HRV were derived from 24-hour electrocardiographic monitoring. Patients had reduced exercise tolerance with abnormal ventilatory response (peak oxygen consumption [VO2max]: 17.8+/-5.5 ml/kg/min, VE/VCO2: 36.0+/-9.8). Correlations were found between HRV measures and etiology, New York Heart Association (NYHA) functional class, and VO2max, but the strongest relation was observed for VE/VCO2 slope (r values from -0.33 to -0.65, p <0.01). In the multiple regression analysis only VE/VCO2 was found to correlate independently with all HRV measurements. To investigate the role of peripheral chemoreceptor overactivity as the mechanism of autonomic imbalance and the increased ventilatory response to exercise, we assessed peripheral chemosensitivity in 22 patients (mean value of peripheral chemosensitivity: 0.62+/-0.34 L/min/%SaO2, significantly higher than in normal controls, mean value: 0.29+/-0.20 L/min/%SaO2 in our laboratory). The activity of the peripheral chemoreflex inversely correlated with all parameters of HRV. Increased ventilatory response to exercise correlated with depressed HRV measures in patients with CHF better than other clinical variables. An important role of the increased peripheral chemosensitivity in this relation may be relevant, being also a potential link between functional severity and sympathovagal imbalance in CHF.


Assuntos
Exercício Físico/fisiologia , Insuficiência Cardíaca/fisiopatologia , Frequência Cardíaca/fisiologia , Respiração/fisiologia , Administração por Inalação , Sistema Nervoso Autônomo/fisiopatologia , Células Quimiorreceptoras/fisiopatologia , Doença Crônica , Eletrocardiografia Ambulatorial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Nitrogênio/administração & dosagem , Valor Preditivo dos Testes , Testes de Função Respiratória
2.
Am J Cardiol ; 79(12): 1645-50, 1997 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-9202356

RESUMO

After acute myocardial infarction, depressed heart rate variability (HRV) has been proven to be a powerful independent predictor of a poor outcome. Although patients with chronic congestive heart failure (CHF) have also markedly impaired HRV, the prognostic value of HRV analysis in these patients remains unknown. The aim of this study was to investigate whether HRV parameters could predict survival in 102 consecutive patients with moderate to severe CHF (90 men, mean age 58 years, New York Heart Association [NYHA] class II to IV, CHF due to idiopathic dilated cardiomyopathy in 24 patients and ischemic heart disease in 78 patients, ejection fraction [EF], 26%; peak oxygen consumption, 16.9 ml/kg/min) after exclusion of patients in atrial fibrilation with diabetes or with chronic renal failure. In the prognostic analysis (Cox proportional-hazards model, Kaplan-Meier survival analysis), the following factors were investigated: age, CHF etiology, NYHA class, EF, peak oxygen consumption, presence of ventricular tachycardia on Holter monitoring, and HRV measures derived from 24-hour electrocardiography monitoring, calculated in the time (standard deviation of all normal RR intervals [SDNN], standard deviation of 5-minute RR intervals [SDANN], mean of all 5-minute standard deviations of RR intervals [SD], root-mean-square of difference of successive RR intervals [rMSSD], and percentage of adjacent RR intervals >50 ms different [pNN50]) and frequency domain (total power [TP], power within low-frequency band [LF], and power within high-frequency band [HF]). During follow-up of 584 +/- 405 days (365 days in all who survived), 19 patients (19%) died (mean time to death: 307 +/- 315 days, range 3 to 989). Cox's univariate analysis identified the following factors to be predictors of death: NYHA (p = 0.003), peak oxygen consumption (p = 0.01), EF (p = 0.02), ventricular tachycardia on Holter monitoring (p = 0.05), and among HRV measures: SDNN (p = 0.004), SDANN (p = 0.003), SD (p = 0.02), and LF (p = 0.003). In multivariate analysis, HRV parameters (SDNN, SDANN, LF) were found to predict survival independently of NYHA functional class, EF, peak oxygen consumption, and ventricular tachycardia on Holter monitoring. The Kaplan-Meier survival curves revealed SDNN < 100 ms to be a useful risk factor; 1-year survival in patients with SDNN < 100 ms was 78% when compared with 95% in those with SDNN > 100 ms (p = 0.008). The coexistence of SDNN < 100 ms and a peak oxygen consumption < 14 ml/kg/min allowed identification of a group of 18 patients with a particularly poor prognosis (1-year survival 63% vs 94% in the remaining patients, p <0.001). We conclude that depressed HRV on 24-hour ambulatory electrocardiography monitoring is an independent risk factor for a poor prognosis in patients with CHF. Whether analysis of HRV could be recommended in the risk stratification for better management of patients with CHF needs further investigation.


Assuntos
Cardiomiopatia Dilatada/complicações , Insuficiência Cardíaca/mortalidade , Insuficiência Cardíaca/fisiopatologia , Frequência Cardíaca , Isquemia Miocárdica/complicações , Idoso , Eletrocardiografia Ambulatorial , Feminino , Insuficiência Cardíaca/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Consumo de Oxigênio , Prognóstico , Modelos de Riscos Proporcionais , Medição de Risco , Volume Sistólico , Análise de Sobrevida
3.
Chest ; 102(2): 635-6, 1992 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1643964

RESUMO

A 51-year-old patient with COPD, obesity, and pulmonary hypertension underwent long-term prazosin therapy after a successful hemodynamic response to 1 mg of oral prazosin. The 18-month administration of prazosin, in a dose of 3 mg a day, resulted in continued hemodynamic and echocardiographic benefits.


Assuntos
Hipertensão Pulmonar/tratamento farmacológico , Pneumopatias Obstrutivas/tratamento farmacológico , Prazosina/uso terapêutico , Humanos , Hipertensão Pulmonar/etiologia , Pneumopatias Obstrutivas/complicações , Masculino , Pessoa de Meia-Idade , Obesidade/complicações , Obesidade/tratamento farmacológico , Indução de Remissão , Fatores de Tempo
4.
Chest ; 119(3): 818-23, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11243963

RESUMO

OBJECTIVE: To evaluate risk factors in medically treated patients with chronic pulmonary embolism (CPE) who are not suitable candidates for definitive surgical therapy. STUDY DESIGN: A total of 53 consecutive patients with angiographically confirmed CPE were involved. Four patients underwent pulmonary endarterectomy, and 49 patients received continuous anticoagulation therapy and were followed up over an average period of 18.7 months (range, 6 to 72 months). RESULTS: Sixteen patients died during the follow-up period, mostly from progressive right ventricle failure. Among the nonsurvivors, 12.5% had distal CPE and 87.5% had proximal CPE (p = 0.03). The survivors had a higher (mean +/- SD) level of PaO(2) (59.3 +/- 11 mm Hg) than the nonsurvivors (50.8 +/- 9 mm Hg; p = 0.02), a lower mean pulmonary artery pressure (mPAP; 30.3 +/- 15 mm Hg vs 51 +/- 21 mm Hg; p = 0.0004), a lower hematocrit value (40.0 +/- 6 vs 44.2 +/- 6; p = 0.03), and better exercise tolerance (4.8 +/- 3 multiples of resting O(2) consumption [METs] vs 2.5 +/- 1 METs; p = 0.02) achieved during the maximal symptom-limited exercise. The patients with coexisting COPD had a higher mortality rate (62.5%) than those without COPD (37.5%; p = 0.04). Independent risk factors in the Cox analysis were as follows: mPAP (p = 0.04), exercise tolerance (p = 0.02), and COPD (p = 0.04). In the Kaplan-Meier analysis, the patient group with lower mortality achieved > 2 METs (p = 0.02) and had mPAP < 30 mm Hg (p = 0.04). CONCLUSION: The prognosis for the medically treated CPE patients, particularly those with pulmonary hypertension, was unfavorable. The prognostic factors for these patients were mPAP, coexistence of COPD, and severe exercise intolerance.


Assuntos
Anticoagulantes/uso terapêutico , Embolia Pulmonar/tratamento farmacológico , Embolia Pulmonar/mortalidade , Doença Crônica , Endarterectomia , Tolerância ao Exercício , Feminino , Seguimentos , Humanos , Hipertensão Pulmonar/complicações , Pneumopatias Obstrutivas/complicações , Masculino , Pessoa de Meia-Idade , Prognóstico , Artéria Pulmonar/cirurgia , Embolia Pulmonar/complicações , Embolia Pulmonar/cirurgia , Fatores de Risco , Análise de Sobrevida , Fatores de Tempo
6.
Kardiol Pol ; 32(5): 259-65, 1989.
Artigo em Polonês | MEDLINE | ID: mdl-2635238

RESUMO

Examinations were performed in 153 consecutive patients with myocardial infarction (MS), which were divided into two groups. Group I (21 persons) consisted of patients with echocardiographically diagnosed left ventricular mural thrombus, and in group II were patients without evidence of thrombi. Significantly more patients with anterior myocardial infarction were in the the group I, whereas those with inferior MI in the group II. Increased left ventricular wall contractility index and considerably percentage of dyskinesis, mostly of the apex region were stated in the group I. 15 patients (71%) of the group I were treated with heparin, but only 4 of them within 4 hours from the beginning of angina pain. In 4 patients of the group I (19%) thromboembolic complications occurred: in 1 patient during proper anticoagulant therapy and in 3 others without treatment with heparin. Thus mural thrombi were observed in majority in patients with anterior myocardial infarction and were localized in a diskinetic region. Echocardiograms of patients with mural thrombi testified to greater than in others left ventricular function impairment. Heparin administration during first hours of myocardial infarction seemed to lower the incidence of mural thrombi and probably thrombembolic complications.


Assuntos
Cardiopatias/diagnóstico , Infarto do Miocárdio/complicações , Trombose/diagnóstico , Adulto , Idoso , Ecocardiografia , Feminino , Cardiopatias/etiologia , Cardiopatias/fisiopatologia , Ventrículos do Coração/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Contração Miocárdica/fisiologia , Trombose/etiologia , Trombose/fisiopatologia
7.
Kardiol Pol ; 33(11-2): 10-6, 1990.
Artigo em Polonês | MEDLINE | ID: mdl-2096247

RESUMO

60 to 95% pts in the age group below 60 return to work after having* suffered the first M.I. Up to the present moment, it has not been proved whether such return influences in any (positive or negative) way the recurrence of M.I. or the mortality rate. Two groups of pts who underwent M.I. in the years 1976-84 were included in the long term questionnaire observation: 1. 222 men (mean age 49.3 +/- 3.8 yrs) who resumed work and; 2. 153 men (mean age 50.7 +/- 8.4 yrs) who did not return to work after the first M.I. All pts were sent the questionnaires by post annually. The aim of the questionnaire was to establish whether the patient is alive, if he underwent reinfarction and, in case of death--what was its cause. Until 1985 reinfarction occurred in 25%, and until 1989--in 33% of the pts who resumed work, and 42% of pts who did not. The mean value of reinfarction was about 1.4 in the first group and 1.5 in the latter. Until 1985 the death rate was respectively 15% and 12%. Until 1989--the death rate was 28% and 30%. Thus, the differences between those two groups were statistically insignificant. In conclusion, it may--indirectly--speak in favour of resuming work after the first M.I., showing that, although it does not decrease the reinfarction and mortality rates, it also does not increase the risk.


Assuntos
Morte Súbita/etiologia , Infarto do Miocárdio/reabilitação , Reabilitação Vocacional , Adulto , Morte Súbita/epidemiologia , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/mortalidade , Polônia , Recidiva , Inquéritos e Questionários , Fatores de Tempo , População Urbana
8.
Kardiol Pol ; 37(11): 301-5, 1992 Nov.
Artigo em Polonês | MEDLINE | ID: mdl-1283759

RESUMO

Clinical significance of cardiac arrhythmias in patients with advanced and stable chronic obstructive pulmonary disease was assessed 22-24 hour Holter monitoring revealed supraventricular and ventricular arrhythmias in all 65 patients. There was a great variation of arrhythmia quality and quantity in the study group. Among others, 1808 complex ventricular extrasystoles in 33 patients and 302 episodes of nonsustained ventricular tachycardia in 19 patients were recorded. No sustained symptomatic ventricular arrhythmias were observed. We found no correlation between the intensity of ventricular and supraventricular extrasystoles and clinical parameters as assessed by echocardiography, spirometry and gasometry. However, patients with complex ventricular arrhythmias had larger right ventricular diameter in echocardiography. Of 65 studied patients, 14 (21%) died during follow-up ranging from 1 month to 3.2 years, mean 12.2 months. Two outpatients died suddenly. These 14 patients had larger right ventricle and left atrial dimension, more pronounced PaO2 decrease as well as lowered FEV1 as compared to the survivors. No differences in the incidence of cardiac arrhythmias were noted. Summarizing, despite the great prevalence of cardiac arrhythmias in patients with advanced stable COPD we found no life-threatening ventricular arrhythmias during approximately 1500 hours of holter monitoring. Cardiac arrhythmias seem not to influence the prognosis in these patients.


Assuntos
Complexos Cardíacos Prematuros/complicações , Morte Súbita Cardíaca/etiologia , Pneumopatias Obstrutivas/complicações , Taquicardia Ventricular/complicações , Adulto , Idoso , Complexos Cardíacos Prematuros/diagnóstico , Complexos Cardíacos Prematuros/mortalidade , Ecocardiografia , Eletrocardiografia Ambulatorial , Feminino , Humanos , Hipertrofia Ventricular Direita/diagnóstico , Hipertrofia Ventricular Direita/etiologia , Masculino , Pessoa de Meia-Idade , Prognóstico , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/mortalidade , Fatores de Tempo
9.
Kardiol Pol ; 39(10): 281-4, 1993 Oct.
Artigo em Polonês | MEDLINE | ID: mdl-8246356

RESUMO

A case of a 53-year old man is presented who developed postpericardiotomy syndrome and subsequently constrictive pericarditis following prosthetic aortic valve replacement due to severe aortic stenosis. The diagnosis was based on clinical picture and confirmed invasively. Nearly total excision of thickened fibrous pericardium resulted in a slow but full disappearance of constriction signs.


Assuntos
Estenose da Valva Aórtica/cirurgia , Próteses Valvulares Cardíacas , Pericardiectomia/efeitos adversos , Pericardite Constritiva/etiologia , Valva Aórtica/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Pericardite Constritiva/cirurgia , Síndrome
10.
Kardiol Pol ; 38(1): 26-8, 1993 Jan.
Artigo em Polonês | MEDLINE | ID: mdl-8230972

RESUMO

We compared 8 patients with COPD and fixed atrial fibrillation (group I) and 46 patients with COPD and sinus rhythm in ecg (group II). None of the patients had valvular heart disease, arterial hypertension or clinical signs of coronary artery disease. The studied groups did not differ while comparing their gas measurements, spirometry, pulmonary hypertension and right ventricular diameter (as measured in echo study). Patients with fixed atrial fibrillation had larger circuit and area of right atrium (p = 0.001), left atrial and left ventricular diameter (p = 0.001) as well as lower LV function (expressed by FS%). In conclusion, enlargement of both atria may be considered as a cause for fixed atrial fibrillation in patients with COPD. However symptomless coronary artery disease rather then COPD may be the reason for this arrhythmia.


Assuntos
Fibrilação Atrial/etiologia , Pneumopatias Obstrutivas/complicações , Idoso , Doença das Coronárias/complicações , Ecocardiografia , Eletrocardiografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes de Função Respiratória
11.
Kardiol Pol ; 32(5): 283-7, 1989.
Artigo em Polonês | MEDLINE | ID: mdl-2635240

RESUMO

Authors presented intravitally diagnosed and well echocardiographically supplied documentary evidence for a huge thrombus positioned in the left atrioventricular ostium in a 52 years old woman within two months of Björk-Shiley mitral valve replacement because of a mitral valve disease.


Assuntos
Próteses Valvulares Cardíacas/efeitos adversos , Valva Mitral/patologia , Trombose/diagnóstico , Ecocardiografia , Ecocardiografia Doppler , Feminino , Humanos , Pessoa de Meia-Idade , Trombose/mortalidade , Trombose/patologia
12.
Kardiol Pol ; 37(7): 3-7, 1992 Jul.
Artigo em Polonês | MEDLINE | ID: mdl-1405196

RESUMO

Chronic enalapril therapy was assessed in 11 patients with cor pulmonale due to chronic obstructive pulmonary disease. Enalapril was added to the maintenance dose of diuretics and digitalis and when clinical stabilisation was achieved haemodynamics, spirometry, blood gases and maximal treadmill exercise test accompanied by +pulse oximetry were performed before and after 30 days, 10-20 mg a day, enalapril therapy. Haemodynamic study showed moderate but significant decrease in mean pulmonary artery pressure, from 24 +/- 3 to 21 +/- 5 mmHg (p = 0.05). There were no substantial differences in cardiac output as well as in blood gases and spirometry after enalapril therapy. Slight decrease in oxygen delivery, on an average from 9157 +/- 3808 to 8074 +/- 3574 (p = NS), was accompanied by a concomitant fall in haemoglobin. We noted significant improvement of maximal exercise test results after enalapril therapy. Maximal workload achieved and the time of exercise increased. It was accompanied by subjective improvement as assessed by Borg scale. We observed no adverse effects of enalapril during one month therapy in patients with cor pulmonale and COPD.


Assuntos
Enalapril/uso terapêutico , Tolerância ao Exercício/efeitos dos fármacos , Pneumopatias Obstrutivas/fisiopatologia , Circulação Pulmonar/efeitos dos fármacos , Doença Cardiopulmonar/tratamento farmacológico , Respiração/efeitos dos fármacos , Idoso , Enalapril/administração & dosagem , Teste de Esforço , Tolerância ao Exercício/fisiologia , Feminino , Hemodinâmica/efeitos dos fármacos , Hemodinâmica/fisiologia , Humanos , Pneumopatias Obstrutivas/etiologia , Masculino , Pessoa de Meia-Idade , Circulação Pulmonar/fisiologia , Doença Cardiopulmonar/etiologia , Doença Cardiopulmonar/fisiopatologia , Respiração/fisiologia , Testes de Função Respiratória , Fatores de Tempo
13.
Kardiol Pol ; 38(4): 267-70, 1993 Apr.
Artigo em Polonês | MEDLINE | ID: mdl-8411832

RESUMO

The clinical picture, differential diagnosis and prognosis in chronic thromboembolic pulmonary hypertension (CTEPH) is being discussed on the basis of a dozen of the authors' cases. The clinical course of CTEPH in 2 patients fulfilling the main criterium for pulmonary thromboendarterectomy and undergoing one year anticoagulation is examined. As a result patient with one large pulmonary vessel occlusion (a. lobaris superior sinistra) improved his clinical status as well as hemodynamic and echocardiographic outcome. In patient with multivessel pulmonary occlusion gradual clinical aggravation and hemodynamic-echocardiographic progression of CTEPH was observed.


Assuntos
Hipertensão Pulmonar/diagnóstico , Embolia Pulmonar/diagnóstico , Adulto , Doença Crônica , Ecocardiografia , Humanos , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/terapia , Masculino , Prognóstico , Embolia Pulmonar/complicações , Embolia Pulmonar/terapia
14.
Kardiol Pol ; 33(6): 358-64, 1990.
Artigo em Polonês | MEDLINE | ID: mdl-2084301

RESUMO

The value of vasodilatatory treatment of pulmonary hypertension due to chronic obturative pulmonary disease (c.o.p.d.) is still controversial. However in patients with c.o.p.d. causal treatment as well as chronic domestic oxygen therapy have a wide range of limitations. Among vasodilator alpha-1 blockers show less vasodilator-related adverse effects, and as known from acute trials they exert a potent effect on pulmonary circulation in patients with pulmonary hypertension and c.o.p.d. Prazosin was studied in 11 patients (10 men, 1 women) aged 63 +/- 7 years with advanced c.o.p.d. (FVC 1.8 +/- 0.41, FEV1 0.99 +/- 0.55 l) (s) after their clinical stabilisation. In 4 of them prazosin was added to the maintenance dose of diuretics and digitalis. Subjective status, NYHA functional class, spirometric (FVC, FEV1) and gaseous (PaO2, PCO2) parameters, weight, systemic blood pressure, and heart rate were noted. During Swan-Ganz catheterization mean pulmonary artery pressure (MPAP), right ventricular end-diastolic pressure (RVEDP), pulmonary wedge pressure (PCWP), cardiac output (CO), systemic (SVR) and pulmonary (PVR) vascular resistance were measured. The acute trial with 1 mg prazosin taken orally was followed by 2- and 6-week of 3 mg prazosin treatment assessment. After a single dose of 1 mg prazosin there was a significant decrease in MPAP from 36 +/- 9 to 28 +/- 10 (p = 0.001) and 44% decrease in RVEDP (p = 0.05). CO increased by 16% (p = 0.01). The fall in PVR (30%, p = 0.01) exceeded that in SVR (17%, NS). No adverse effects were observed. During 2-week 3 mg a day prazosin therapy 2 patients were excluded following dyspnea and systemic hypotonia.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Hemodinâmica/efeitos dos fármacos , Hipertensão Pulmonar/tratamento farmacológico , Pneumopatias Obstrutivas/fisiopatologia , Prazosina/administração & dosagem , Administração Oral , Idoso , Hemodinâmica/fisiologia , Humanos , Hipertensão Pulmonar/etiologia , Hipertensão Pulmonar/fisiopatologia , Pneumopatias Obstrutivas/complicações , Pessoa de Meia-Idade , Fatores de Tempo
15.
Pol Merkur Lekarski ; 3(14): 68-70, 1997 Aug.
Artigo em Polonês | MEDLINE | ID: mdl-9480178

RESUMO

Electrocardiogram is commonly used in the diagnosis of cor pulmonale in patients with chronic obstructive pulmonary disease (COPD). Pulmonary hemodynamics being the definite method for diagnosis the disease can be used to vary the ecg criteria for diagnosis cor pulmonale. After excluding patients with old myocardial infarction and with pulmonary wedge pressure > 12 mm Hg in 66 patients aged 65.2 with advanced COPD (FEV1 0.78 +/- 0.3 litre) pulmonary hemodynamics and ecg were performed at the same time. The signs of right ventricular hypertrophy were sought for using 3 sets of criteria: the World Health Organisation criteria, new compiled Lehtonen et al. Criteria and right ventricular precordial leads. WHO criteria had a specificity and sensitivity of 50% and 57.6%, the modified right precordial leads-53% and 64.5% and compiled Lehtonen's criteria -57% and 59% respectively. In 32 patients with mild pulmonary hypertension (20-29 mm Hg) sensitivity of WHO criteria was 46.8%, right precordial leads -51.6%, and Lethonen and co. Criteria -50%, in 10 patients with moderate pulmonary hypertension (30-39 mm Hg) 59%-62.5%-50%, in 9 patients with severe hypertension (> or = 40 mm Hg) 100%-100%-100% respectively. Our studies confirm the poor sensitivity and of ecg criteria for diagnosis of cor pulmonale (pulmonary hypertension) in COPD. However, in mild and moderate pulmonary hypertension, sensitivity of ecg diagnosis of cor pulmonale is improved if right modifieds precordial leads are used. New, compiled Lehtonen's criteria failed to improved diagnosis of diagnosis of cor pulmonale. All studied sets of criteria are highly sensitive in COPD patients with severe pulmonary hypertension.


Assuntos
Eletrocardiografia/normas , Doença Cardiopulmonar/diagnóstico , Testes de Função Respiratória/normas , Adulto , Idoso , Feminino , Hemodinâmica , Humanos , Hipertensão Pulmonar/diagnóstico , Hipertensão Pulmonar/etiologia , Hipertrofia Ventricular Direita/diagnóstico , Pneumopatias Obstrutivas/complicações , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Organização Mundial da Saúde
16.
Wiad Lek ; 43(19-20): 940-4, 1990.
Artigo em Polonês | MEDLINE | ID: mdl-2075734

RESUMO

14 patients with chronic bronchitis were observed after from 1.5 to 8 years of regular treatment with corticosteroids of sustained action given intramuscularly. The patients were analysed from the standpoint of age, sex, duration of corticosteroid treatment, type and dose of the drugs, and smoking. In 9 of them accelerated development of osteoporosis was noted its appearance depended significantly only on age and sex.


Assuntos
Asma/tratamento farmacológico , Betametasona/análogos & derivados , Bronquite/tratamento farmacológico , Broncodilatadores/efeitos adversos , Osteoporose/induzido quimicamente , Triancinolona Acetonida/efeitos adversos , Triancinolona/análogos & derivados , Adulto , Idoso , Asma/complicações , Betametasona/administração & dosagem , Betametasona/efeitos adversos , Bronquite/complicações , Broncodilatadores/administração & dosagem , Doença Crônica , Combinação de Medicamentos , Quimioterapia Combinada , Humanos , Pessoa de Meia-Idade , Triancinolona/administração & dosagem , Triancinolona/efeitos adversos , Triancinolona Acetonida/administração & dosagem
17.
Wiad Lek ; 42(22-24): 1104-9, 1989.
Artigo em Polonês | MEDLINE | ID: mdl-2637547

RESUMO

Twenty-one patients with infectious endocarditis are reported. The diagnosis was based on finding of at least three clinical symptoms and signs, including systemic manifestations, cardiovascular signs such as the appearance of a new or changing symptoms of cardiac failure, episodes of embolism and abnormalities in laboratory investigations and features of valvular involvement by the inflammatory process, principal changing endocardium image was evidence of an active inflammatory process. The aetiological factors, diagnostic difficulties, therapeutic results and the usefulness of echocardiography in the diagnosis of infectious endocarditis are discussed.


Assuntos
Ecocardiografia , Endocardite Bacteriana/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Micrococcus/isolamento & purificação , Pessoa de Meia-Idade , Infecções Estafilocócicas/diagnóstico , Infecções Estreptocócicas/diagnóstico
18.
Pneumonol Alergol Pol ; 66(9-10): 464-7, 1998.
Artigo em Polonês | MEDLINE | ID: mdl-10354696

RESUMO

UNLABELLED: Whether rehabilitation may be as beneficial as oxygen therapy (T) in the management of chronic obstructive pulmonary disease (COPD) is still not known. The aim of the was to compare the effects of T or R on exercise tolerance (ET) and percutaneous oxygen saturation (SO2) at rest and at the peak exercise in 21 patients with COPD (FEV1, 1.29 L +/- 0.5) Eleven patients with COPD were treated with oxygen (17 hour per day) for 14 days and 10 patients were rehabilitated. Both groups did not differ in age 63.7 vs 69.3 years, in the baseline values of FEV1, PaCO2 and PaO2 and resting SO2%. Before the study patients R and T had similar resting SO2 values and ET (4.5 +/- 1 vs 3.4 +/- 2 METs, p = NS), but those in the R group revealed higher drop in SO2 at peak exercise test (10.9 vs 3.4%, p = 0.007). RESULTS: We found no significance impact of 14- day R and 14- day T on results of exercise test and exercise pulse oximetry in studied patients. However, rehabilitated patients, as opposite to patients on oxygen therapy had tendency to increase number of Mets and to diminish maximal drop in pulse oximetry during exercise. As a result, when we compared group R i T after study patients of R group differed from T patients with number of METs achieved (4.6 vs 3.0, p = 0.02), whereas maximal drop in SO2 at the peak exercise test in R and T patients equalized (7.9 +/- 7 vs 3.2 +/- 3%, p = NS). We conclude that the results of our short term study may suggest better effects of rehabilitation than oxygen therapy on exercise tolerance and oxygen saturation during exercise in COPD patients and justify further studies.


Assuntos
Pneumopatias Obstrutivas/terapia , Idoso , Teste de Esforço , Humanos , Pneumopatias Obstrutivas/reabilitação , Pessoa de Meia-Idade , Oxigênio/sangue , Consumo de Oxigênio , Oxigenoterapia , Testes de Função Respiratória , Resultado do Tratamento
19.
Pneumonol Alergol Pol ; 62(9-10): 496-500, 1994.
Artigo em Polonês | MEDLINE | ID: mdl-7866322

RESUMO

It is suggested that ventricular arrhythmias may be the reason of sudden death in stable patients with COPD. Strenuous effort might provoke danger ventricular arrhythmias in those patients. The impact of maximal exercise test on cardiac ventricular arrhythmias was studied in 24 patients with advanced chronic obstructive pulmonary disease (COPD). The treadmill, self limited exercise test according to Bruce protocol and accompanied by pulse oximetry was performed during 24 hour Holter monitoring. We found ventricular extrasystoles in all patients, in an average 492 +/- 770, complex ventricular extrasystoles in 17 patients and nonsustained ventricular tachycardia in 8 patients. 81% of all ventricular extrasystoles, 80% complex ventricular extrasystoles and 70% nonsustained ventricular tachycardia occurred during the test and up to 2 hour after the test. Patients with complex ventricular arrhythmias were younger and mostly achieved more MET during exercise, but they did not differ in advancing of COPD as measured by spirometry, gas measurements and echocardiography. Although maximal exercise test enhances ventricular arrhythmias it produced no sustained, symptomatic ventricular arrhythmias in patients with advanced and stable COPD.


Assuntos
Arritmias Cardíacas/etiologia , Pneumopatias Obstrutivas/complicações , Esforço Físico/fisiologia , Idoso , Arritmias Cardíacas/diagnóstico , Morte Súbita/etiologia , Eletrocardiografia Ambulatorial , Teste de Esforço , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/etiologia
20.
Pneumonol Alergol Pol ; 59(3-4): 132-6, 1991.
Artigo em Polonês | MEDLINE | ID: mdl-1843908

RESUMO

An intensive 14 day respiratory rehabilitation program was carried out in 24 COPD patients of mean age 66.0 +/- 10.0 yrs (FVC 1.56 +/- 0.52 L, FEV1 0.94 +/- 0.4 L/s). A statistically objective improvement was seen measured by the 100 meter tread mill test (p = 0.001) which was not seen in spirometric analysis. Seventeen patients reported a subjective improvement in their clinical state. The authors have demonstrated usefulness of the 100 meter walk test in analysis of rehabilitation processes.


Assuntos
Exercícios Respiratórios , Broncodilatadores/administração & dosagem , Pneumopatias Obstrutivas/reabilitação , Massagem , Respiração/fisiologia , Administração por Inalação , Adulto , Idoso , Terapia Combinada , Teste de Esforço , Feminino , Humanos , Pneumopatias Obstrutivas/fisiopatologia , Pneumopatias Obstrutivas/terapia , Masculino , Pessoa de Meia-Idade , Respiração/efeitos dos fármacos , Testes de Função Respiratória , Autoavaliação (Psicologia) , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA